HiFiBiO Therapeutics is an emerging multinational biotherapeutics company mobilizing the human immune system to combat disease. The company integrates deep-rooted biological expertise with our comprehensive single-cell profiling technologies to rapidly discover and advance a pipeline of antibody drugs to treat cancer and autoimmune disorders. In addition, HiFiBiO Therapeutics aspires to benefit patients through open-innovation partnerships with industry and academia. 

Biotechnology

HiFiBiO

Liang Schweizer

Timothy Miller

Jack Pollard

Melissa Harney

Robert Andtbacka

Chao Kong

Yun-Yueh Lu

Roshan Kumar

Sami Ellouze

Vincent Tse

He Zhou

Francisco Adrian

Steven Chen

Edward Rocnik

The Leadership Team at HiFiBiO Therapeutics is responsible for guiding the strategic vision and direction of the company. Comprised of the founders and key scientific leaders, this team drives the integration of innovative research and advanced biotherapeutics development, while fostering collaborations with industry and academic partners to enhance the company’s capabilities in mobilizing the human immune system to tackle cancer and autoimmune diseases. Their collective expertise ensures that HiFiBiO remains at the forefront of therapeutic advancements and patient care.

Leadership Team

Research and Development

Scientific Research Team

Leadership Team

About

Team members

Other teams at HiFiBiO

Research and Development

Scientific Research Team